Capital expenditure increased 31.1%
Capital expenditure changed +31.1% from the comparable as-filed period.
$118.8M→$155.7M0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MRVL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 333.9%
Cash & equivalents changed +333.9% from the comparable as-filed period.
$885.9M→$3.8B0 prior comparisons
Free-cash-flow proxy increased 125.6%
Free-cash-flow proxy changed +125.6% from the comparable as-filed period.
$214.1M→$483.1M0 prior comparisons
Gross profit increased 32.4%
Gross profit changed +32.4% from the comparable as-filed period.
$952.4M→$1.3B0 prior comparisons
Inventory increased 30.8%
Inventory changed +30.8% from the comparable as-filed period.
$1.1B→$1.4B0 prior comparisons
Net income decreased 80.6%
Net income changed -80.6% from the comparable as-filed period.
$177.9M→$34.5M0 prior comparisons
Operating cash flow increased 91.9%
Operating cash flow changed +91.9% from the comparable as-filed period.
$332.9M→$638.8M0 prior comparisons
Operating income increased 25.4%
Operating income changed +25.4% from the comparable as-filed period.
$270.6M→$339.4M0 prior comparisons
Research & development increased 28.5%
Research & development changed +28.5% from the comparable as-filed period.
$507.7M→$652.3M0 prior comparisons
Revenue increased 27.6%
Revenue changed +27.6% from the comparable as-filed period.
$1.9B→$2.4B0 prior comparisons
Selling, general & administrative increased 38.6%
Selling, general & administrative changed +38.6% from the comparable as-filed period.
$186.4M→$258.4M0 prior comparisons
Stock-based compensation increased 46.1%
Stock-based compensation changed +46.1% from the comparable as-filed period.
$142.1M→$207.6M0 prior comparisons
Debt increased 17.2%
Debt changed +17.2% from the comparable as-filed period.
$4.2B→$5.0B0 prior comparisons
Gross margin increased by 1.90 points
Gross margin moved +1.90 percentage points from the comparable as-filed period.
50.25%→52.15%0 prior comparisons
Capex / revenue increased by 0.17 points
Capex / revenue moved +0.17 percentage points from the comparable as-filed period.
6.27%→6.44%0 prior comparisons
Operating margin decreased by 0.24 points
Operating margin moved -0.24 percentage points from the comparable as-filed period.
14.28%→14.04%0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.